Welcome to the Funding Opportunities website. Below you will find a listing of various Funding Opportunities. Before applying, please make sure that you sign in, by clicking "Login" above. If you have never registered before, please create a new account. Creating an account will allow you to go back and make edits to your application.
Pilot Projects / Funding Opportunities
2017 Outstanding Investigator Award (R35)
Deadline: 9/29/2016 (Prior to Midnight) - 0 Day(s) Left
The National Cancer Institute (NCI) encourages investigators with outstanding records of productivity in cancer research to apply for the 2017 Outstanding Investigator Award (OIA) (R35). Cancer researchers, nominated by their institutions, who have served as a principal investigator on an NCI grant for the last five years and have demonstrated outstanding cancer research productivity are eligible to apply. Interested applicants should read the PAR closely for detailed eligibility requirements (PAR-16-411).
Johns Hopkins-Allegheny Health Network Cancer Research Fund
Deadline: 11/14/2016 (Prior to Midnight) - 45 Day(s) Left
The Johns Hopkins University School of Medicine announces the third annual request for applications (RFA) for the Hopkins-Allegheny Health Network (AHN) Cancer Research Fund. Hopkins-AHN Awards will fund cancer research projects at the level of $100,000 direct costs per year, with an award term of two years.
The expectation is that Hopkins-AHN Awards will spark synergistic interactions among investigators and catalyze scientific achievements of the highest quality and impact. Applications are welcomed from across the spectrum of fundamental, translational, clinical, and epidemiologic research. Applications are similarly free to focus on specific organ sites or on issues that span multiple cancer types. Applications will be evaluated by reviewers from both the Sidney Kimmel Comprehensive Cancer Center (SKCCC) and the Allegheny Health Network Cancer Institute (AHN CI) and will be based on their potential to influence our scientific understanding of cancer and our clinical, operational, and financial management of the disease.